Leadership & Pay ·
Endovia Health Sciences, Inc. entered into employment agreements on August 20, 2026, appointing Brady Cobb as Interim…
SBEVWSplash Beverage Group, Inc.
Endovia Health Sciences, Inc. entered into employment agreements on August 20, 2026, appointing Brady Cobb as Interim CEO and Michael Bondurant as Interim COO. Mr. Cobb receives a $300,000 annual base salary and Mr. Bondurant $275,000. Both executives are eligible for performance bonuses tied to market capitalization milestones: $50,000 increments at $5 million and $10 million increases above the agreement date baseline by October 30 and December 31, 2026, respectively, plus a variable bonus capped at $300,000 for further gains in 2026. Mr. Cobb received 231,250 stock options and Mr. Bondurant 200,000 options, with potential RSU grants subject to shareholder approval. The company operates in the health sciences sector.